2009 study posted for filing
Contact: Angela Colmone
American Journal of Pathology
The ‘see food’ diet
Bethesda, MD — Current research suggests that a diet high in omega-3 fatty acids may help prevent one of the leading causes of legal blindness among the elderly. The related report by Tuo et al, “A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration,” appears in the August 2009 issue of the American Journal of Pathology.
Age-related macular degeneration (AMD), loss of vision in the center of the visual field (macula) due to retinal damage, is one of the leading causes of legal blindness among the elderly. Approximately 10% of people from 66 to 74 years of age will develop some level of macular degeneration, making it difficult for them to read or even recognize faces.
A diet high in omega-3 fatty acids has been found to protect against a variety of diseases including atherosclerosis and Alzheimer’s disease. Retrospective studies have suggested that diets high in fish oil or omega-3 fatty acids may also contribute to protection against AMD. A group led by Dr. Chi-Chao Chan at the National Eye Institute in Bethesda, MD examined the direct effect of omega-3 fatty acids on a mouse model of AMD. A diet with high levels of omega-3 fatty acids resulted in slower lesion progression, with improvement in some lesions. These mice had lower levels of inflammatory molecules and higher levels of anti-inflammatory molecules, which may explain this protective effect.
Tuo et al suggest that “a diet enriched in EPA and DHA can ameliorate the progression of retinal lesions in their mouse model of AMD” and that “the results in these mice are in line with the epidemiological studies of AMD risk reduction by long chain n-3 fatty acids.” The results “further provide the scientific basis for the application of omega-3 fatty acids and their biologically active derivatives in the prevention and treatment of AMD.” In future studies, Dr. Chan and colleagues plan to use this murine model “to evaluate [other] therapies that might delay the development of AMD.” Their ongoing projects include the “testing of systematic delivered pharmacochaperones and antioxidative molecules, as well as intraocularly delivered gene therapies.”
This work was supported by grants from The Intramural Research Program of the National Eye Institute, the National Institutes of Health, and the American Health Assistance Foundation.
Tuo J, Ross RJ, Herzlich AA, Shen D, Ding X, Zhou M, Coon SL, Hussein N, Salem Jr N, Chan C-C: A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol 2009 175: 799-807
For press copies of the articles, please contact Dr. Angela Colmone at 301-634-7953 or firstname.lastname@example.org.
For more information on Dr. Chi-Chao Chan, please contact:
Office of Communication
National Eye Institute, NIH
Building 31, Room 6A32
31 Center Drive, MSC 2510
Bethesda, MD 20892-2510.
The American Journal of Pathology, official journal of the American Society for Investigative Pathology, seeks to publish high-quality, original papers on the cellular and molecular biology of disease. The editors accept manuscripts that advance basic and translational knowledge of the pathogenesis, classification, diagnosis, and mechanisms of disease, without preference for a specific analytic method. High priority is given to studies on human disease and relevant experimental models using cellular, molecular, animal, biological, chemical, and immunological approaches in conjunction with morphology.
Categories: All Posts, Disease and Conditions, Missed - Medical Breakthroughs